000 01481 a2200421 4500
005 20250516143727.0
264 0 _c20140127
008 201401s 0 0 eng d
022 _a1098-1004
024 7 _a10.1002/humu.22332
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSikkema-Raddatz, Birgit
245 0 0 _aTargeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics.
_h[electronic resource]
260 _bHuman mutation
_cJul 2013
300 _a1035-42 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCardiomyopathies
_xdiagnosis
650 0 4 _aCardiomyopathy, Dilated
_xdiagnosis
650 0 4 _aExons
650 0 4 _aHigh-Throughput Nucleotide Sequencing
_xmethods
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
650 0 4 _aSequence Analysis, DNA
_xmethods
700 1 _aJohansson, Lennart F
700 1 _ade Boer, Eddy N
700 1 _aAlmomani, Rowida
700 1 _aBoven, Ludolf G
700 1 _avan den Berg, Maarten P
700 1 _avan Spaendonck-Zwarts, Karin Y
700 1 _avan Tintelen, J Peter
700 1 _aSijmons, Rolf H
700 1 _aJongbloed, Jan D H
700 1 _aSinke, Richard J
773 0 _tHuman mutation
_gvol. 34
_gno. 7
_gp. 1035-42
856 4 0 _uhttps://doi.org/10.1002/humu.22332
_zAvailable from publisher's website
999 _c22652870
_d22652870